iSTAR Medical shows initial positive progress of US STAR|V

iSTAR Medical shows initial positive progress of US STAR-V trial for ...

The STAR-V trial is a US FDA-approved pivotal study assessing the safety and efficacy of MINIject in over 350 patients with primary open-angle ...

iSTAR Medical shows initial positive progress of US STAR-V trial for ...

The pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the US, has received positive feedback from glaucoma surgeons ...

iSTAR Medical initiates international STAR-VI trial for the use of ...

Patients will be followed for two years after their cataract surgery and concurrent MINIject® implantation. The primary endpoint of the trial is ...

iSTAR Medical shows initial positive progress of US STAR-V

For immediate release iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject Pivotal trial of MINIject, STAR-V, now initiated in...

iSTAR Medical receives U.S. FDA approval to start pivotal trial for ...

The STAR-V study will investigate MINIjectTM in over 350 patients with primary open angle glaucoma. World-leading glaucoma surgeons in the US, ...

iSTAR Medical shows initial positive progress of US STAR-V trial for ...

For immediate release iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject Pivotal trial of MINIject, STAR-V, now initiated in 13 ...

Miniject STAR-V Trial Initiated, Progress Reported

Miniject, Istar Medical's supraciliary MIGS device, has now initiated a trial in 13 sites across the United States with positive feedback on initial ...

iSTAR Medical shows initial positive progress of US STAR-V trial for ...

iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject · NASDAQ Market News · Global Vaccine Contract Manufacturing Market Growth Forecasts ...

iSTAR Medical Presents Positive Consistent Results for MINIject ...

WAVRE, Belgium — 8 June 2022: iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients, presented two-year safety ...

US STAR-V Trial – MedicalDeviceIndustry.com

iSTAR Medical Shows Initial Positive Progress of US STAR-V Trial for MINIject ... Pivotal trial of MINIject, STAR-V, now initiated in 13 sites [...] By ...

A look back at 2021 and a vision for 2022 - iSTAR Medical

As we enter a new year, iSTAR Medical's CEO Michel Vanbrabant reflects on 2021 and the progress iSTAR Medical has made in the development of ...

iStar Medical announces positive 3-year results from STAR-GLOBAL ...

iStar Medical has announced positive 3-year results from the STAR-GLOBAL trial for the MINIject® in open-angle glaucoma patients.

iSTAR Medical's glaucoma device MINIject shows positive one-year ...

iSTAR Medical, a medtech company developing minimally invasive ophthalmic implants for treatment of patients with glaucoma, announced positive one-year ...

Our extraordinary achievements in 2022 - iSTAR Medical

As 2022 comes to an end, iSTAR Medical's CEO, Michel Vanbrabant, looks back on the extraordinary progress iSTAR Medical has made and the ...

David Stocker on LinkedIn: Exciting to see our US IDE trial recrute ...

... #TrialProgress #MedTech #Glaucoma #MIGS · iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject · 10 · Like Comment. Share. Copy

iSTAR Medical receives U.S. FDA approval to start pivotal trial for ...

The STAR-V study will investigate MINIject TM in over 350 patients with primary open angle glaucoma. World-leading glaucoma surgeons in the US, Canada and ...

Istar Medical SA - Manufacturer Of Minimally-Invasive Glaucoma ...

Pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the US Positive feedback from world-leading glaucoma surgeons involved in the trial MINIject ...

iSTAR Medical presents positive three-year results for MINIject ...

Interim data from 48 patients in the STAR-GLOBAL trial who completed three-year follow-up was presented by Dr Inder Paul Singh (The Eye Centers ...

iSTAR Medical - Company Profile - Tracxn

iSTAR Medical - Developer of minimally-invasive glaucoma surgery (MIGS) implant. Raised a total funding of $60.8M over 4 rounds from 15 ...

iSTAR Medical initiates international STAR-VI trial for the

iSTAR Medical's STAR-VI trial is a prospective, interventional, multi-center, single-arm study which seeks to implant a total of 30 patients at ...